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Abstract
Background: Cr(V) species are formed during the intracellular reduction of Cr(VI), a ubiquitous
environmental pollutant. In this study, the acute toxicity of a physiologically stable Cr(V)
compound, [CrV-BT]2-  (BT = bis(hydroxyethyl)aminotris(hydroxymethyl)methane) was
investigated in the male reproductive system of sexually mature 60-day-old male ICR-CD1 mice.
Methods: Eight-week-old animals were subcutaneously injected daily with a dose of ca 8 µmol of
Cr/mouse, during 5 days. The control group was injected with 0.5 mL of BT buffer. Testis and
epididymis morphology was evaluated using light and transmission electron microscopy. Epididymal
sperm counts, motility and acrosome integrity were also assayed using standard methods.
Results: Seminiferous epithelium abnormalities were detected in the CrV-BT experimental group,
including intraepithelial vacuolation, and remarkable degeneration of Sertoli cells, spermatocytes
and spermatids. The premature release of germ cells into the tubular lumen was also evident.
Histological evaluation of epididymal compartments revealed apparently normal features.
However, the epididymal epithelium presented vacuolation. [CrV-BT]2- induced a reduction in
sperm acrosome integrity. However, sperm motility and density were not significantly affected.
Conclusion: This in vivo study using a Cr(V) compound, provides evidence for the potential
reproductive hazards caused on male reproductive system by species containing chromium in
intermediate oxidation states.
Background
Cr(VI) compounds have been declared potent occupa-
tional carcinogens by IARC [1]. Although the first report
on the development of lung cancer in the chrome ore
industry appeared ca 80 years ago [2], several epidemio-
logical studies among workers of almost one hundred dif-
ferent professional categories (chrome plating, stainless-
steel welding, pigment and leather tanning) were pub-
lished since [3-5]. Numerous and different in vitro and/or
in vivo studies have been undertaken either in animals or
in humans and today it is known that there is a close rela-
tionship between workers health and the amounts of
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industrial pollution provoked by industries manufactur-
ing chromium containing materials [1,6,7].
Cytotoxicity and carcinogenicity of Cr(VI) depend on
intracellular reduction towards stable and inert Cr(III)
compounds [8,9]. During this process Cr(V) and Cr(IV)
intermediate states have been gaining major relevance
[10-12]. Cr(V) compounds appear as good candidates to
elucidate the not yet fully understood mechanism of the
intracellular trail of chromium [11,12].
Cr(V) complexes possessing α-hydroxy-carboxylate moie-
ties are believed to act as both structural and biomimetic
models for a range of Cr(V) species generated in vivo from
Cr(VI) in intracellular media [11,12]. The [CrV-BT]2- com-
plex, has a "design" which exploits an adequate co-ordi-
nation capacity to the Cr metal centre together with a
strong chelate effect, and is stable under physiologically
conditions over a rather long period of time, and therefore
seems to be an adequate Cr(V) complex to be explored for
in vivo studies [13].
Chromium  in vivo studies in small rodents have dealt
essentially with the effects of this element in the usual tox-
icological target organs. Recent works concern, for exam-
ple, kidney and liver [10,14], pancreas [15], lungs [6,16-
18], brain [19], male reproductive organs [20], skin [21],
or even blood [22]. These studies have comprised both
particulate chromium compounds, mainly related with
lung pathology [16], together with soluble compounds
containing chromium in all the available oxidation states,
more adequate or available to reach other target organs.
In previous works we have undertaken studies on Cr(VI)
and Cr(V) induced alterations on mouse liver [14], and
spleen histology [23]. Also, the functional properties of
Sertoli cells from mice exposed to Cr(V) were investigated
[24]. The purpose of the present study was to assess the
effects of [CrV-BT]2- on the morphology of testis and epidi-
dymis of mice.
Methods
Bis(hydroxyethyl)aminotris(hydroxymethyl)methane,
(BT) buffer (Fluka) was used and the pH of the solution
was adjusted to 7.4 by addition of diluted HCl.
Preparation of the Cr(V) compound [CrV-BT]2-
[CrV-BT]2- was prepared in situ from a Cr(V) precursor, Na
[CrVO(ehba)2] (ehba = sodium bis(2-ethyl-2-hydroxybu-
tanoate)oxochromato(V)), following a method described
elsewhere [13].
Animals and Treatment
The in vivo studies were carried out on 10 (per group) sex-
ually mature 60-day-old male ICR-CD1 mice (Harlan
Interfauna Iberica SA, Barcelone, Spain). Mice were
housed at a constant temperature (22 +2°C), relative
humidity (40–60%) vivarium on a light-dark 12 h/12 h
cycle; water and food were provided ad libitum; animals
were allowed to acclimatise for one week before experi-
mental use. After this period one group of mice was sub-
cutaneously injected daily with a dose of 8 µmol of Cr/
mouse over 5 days [15]. A control group of animals was
similarly injected with the vehicle (0.5 mL BT). On day
six, all animals were sacrificed, under ether anaesthesia,
for testis and epididymis removal.
All assays with animals were conducted in accordance
with the institutional guidelines for ethics in animal
experiments (Rule n° 86/609/CEE – 24/11/92).
Ultrastructural studies
Body and organ weights were recorded. Some fragments
of testis and cauda epididymis were fixed by immersion in
2.5% glutaraldehyde for 2 hours, postfixed with osmium
tetroxide, and routinely prepared for transmission elec-
tron microscopy studies. Semithin sections, made with a
Supernova Reichert ultramicrotome, were stained with
toluidine blue for light microscopy observation. Ultrathin
sections (golden colour of interference) were also pre-
pared using a diamond knife. Then, these sections were
stained with uranyl acetate and lead citrate, and observed
under a Hitachi electron microscope at 100 kV.
Sperm motility
Both epididymides were removed to a Petri dish contain-
ing Modified Tyrode's medium prepared according to Fra-
ser [25]. The cauda epididymis was disrupted through an
incision with a scissors previously wrapped with Para-
film®, and was kept for 30 min at 35°C to promote the
release of sperm into the medium. Then, sperm were col-
lected with a micropipette (aliquot 20 µl) to a slide for
motility analysis. Sperm motility was determined by
counting all progressive sperm, the non-progressive and
the immotile sperm in the same field. In each preparation
at least 100 sperm was counted. This motility assessment
was repeated in a new preparation from the same semen
sample.
Sperm concentration
A small amount of sperm suspension was collected with a
tube and was centrifuged for 5 min to 1000 g. The pellet
was suspended in new media. A small amount (20 µL) of
suspension was diluted 1:1 with distilled water. The
sperm concentration was determined by counting the
number of cells on a haemocytometer (Neubauer
Improved Chamber).Environmental Health: A Global Access Science Source 2005, 4:9 http://www.ehjournal.net/content/4/1/9
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Acrosome integrity
Acrosome integrity was determined according to Lu and
Shur [26]. The sperm were fixed in 5% formaldehyde in
PBS for 30 min at 23°C. Fixed sperm were collected by
centrifugation at 1000 g for 5 min and were then resus-
pended in 500 µL 0.1 M ammonium acetate pH 9.0.
Sperm were washed once on the buffer and then resus-
pended in 100 µL ammonium acetate. An aliquot (20 µL)
of this suspension was dried on a glass slide and was
stained for 2 min at 23°C with 0.22 Coomassie blue G250
in 50% methanol/10% glacial acetic acid. After staining,
the slides were rinsed with tap water, air-dried and
mounted. The acrosome integrity was assayed by an
intense staining on the anterior region of sperm head
under 400× magnification.
Results
In the current study, all animals survived until the end of
the dosage period. Additionally, no abnormal behaviour
was observed, and at sacrifice, none of the animals evi-
denced any macroscopic lesions. Their body weight at the
start and at the end of the experiment was 32 ± 3 g, and no
loss or gain in body weight was noticed along the experi-
ments. Also, no differences were noted between the organ
weights of controls and Cr(V)-injected animals over the
period of these experiments (testis weight = 267 ± 2 mg;
epididymis = 96 ±1 mg). The seminiferous tubules in con-
trol mice demonstrated regular features (Figure 1A). How-
ever, degenerative histological changes were observed in
the epithelium of seminiferous tubules of treated animals
(Figure 1B). These changes were uniform within the testis,
ranging from Sertoli cells to highly mature germ cells.
Intraepithelial vacuoles were clearly observed. Abnormal-
ities affecting nearly all stages of germ cell development
were seen in the seminiferous tubules, being evident
necrotic mass of germ cells. In addition, all the animals
injected with [CrV-BT]2- were affected equally.
The ultrastructural features of the basal as well as the
upper compartments of the seminiferous tubules in con-
trol animals revealed regular morphology. However, [CrV-
BT]2- injected mice evidenced degenerative changes within
the Sertoli cells and irregular features of spermatids, and
displacement towards the lumen (Figures 2A–C). Necrotic
and vacuolated germ cells were also present.
Epithelial cells of cauda epididymis from [CrV-BT]2-
treated animals also exhibited a large number of vacuoles
(Figure 3). However, other portions like the boundary tis-
sue, revealed apparently normal features.
Table 1 shows that [CrV-BT]2- induced a slight reduction in
sperm motility and density, although the differences
when compared to controls were not statistically signifi-
cant. Sperm acrosome integrity of mice treated with [CrV-
BT]2- was significantly lower than sperm acrosome integ-
rity of the controls.
Discussion
Cr(VI) is known to be toxic to animals and humans [3].
However implementation of both environmental and
occupational regulations have been established to
(A-B) – Light micrographs of the testis Figure 1
(A-B) – Light micrographs of the testis. Toluidine blue staining; (A) Control. Normal germinal epithelium evidencing a 
lumen (*); bar = 40 µm. (B) Cr(V)-treated group. Remarkable degeneration and disorganization of the seminiferous tubules is 
noted. Some intraepithelial vacuoles are evidenced (*). The sloughing of necrotic cells are also seen; bar = 40 µm.Environmental Health: A Global Access Science Source 2005, 4:9 http://www.ehjournal.net/content/4/1/9
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decrease of the hazards caused by the different types of
compounds of this element. Nevertheless their associated
toxicity mechanism(s) still remain unclear. For this rea-
son, a better knowledge of the action of chromium species
in intermediate oxidation states, for example, that Cr(V),
is relevant in the understanding the harmful effects of
chromium.
Mainly due to the poor knowledge of the role of chro-
mium in the intermediate oxidation state Cr(V), which is
considered the first step in the potentially long and harm-
ful Cr(VI) intracellular reduction [1,3,11,12], in vivo
experimental studies with [CrV-BT]2- have been under-
taken in the present work.
The results of this study indicate that Cr(V), in the form of
[CrV-BT]2-, is a male reproductive toxicant, causing several
histological and ultrastructural changes in mice sperma-
togenesis, including alterations in both Sertoli and germ
cells. The presence of strongly stained exfoliated germ
cells in the lumen of seminiferous tubules of [CrV-BT]2-
treated animals demonstrates a degenerative process in
this epithelium. As shown by the results of the present
work, the exfoliation process is remarkable when com-
(A-C) -Electron micrographs of the seminiferous epithelium in Cr(V)-treated group Figure 2
(A-C) -Electron micrographs of the seminiferous epithelium in Cr(V)-treated group. Uranyl acetate and lead cit-
rate staining; (A) Ultrastructural morphology of the basal portion of a seminiferous tubule exhibiting widening of intercellular 
spaces (*) and necrotic germ cells (arrows); Bar = 3 µm; (B) Portion of a degenerative symplast where several nuclei (N) are 
seen; Bar = 2 µm; (C) Abnormal aspect of a late giant spermatid evidencing the head and the neck pieces; N – nucleus; Bar = 1 
µm.
Light micrograph of the epididymis in Cr(V)-treated group Figure 3
Light micrograph of the epididymis in Cr(V)-treated 
group. Some epithelial vacuoles are evidenced (arrow). 
Reduction of cells within the lumen is also shown (*); toluid-
ine blue staining; Bar = 60 µm.Environmental Health: A Global Access Science Source 2005, 4:9 http://www.ehjournal.net/content/4/1/9
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pared with testis injuries reported for other toxicants
[20,27].
Cauda epididymis also presented some epithelial vacuola-
tion. Similar results have been described for the epididy-
mal epithelial cells of rats treated, for example, with lead
acetate [28].
These results suggest that [CrV-BT]2-  beyond inducing
alterations in testis and epididymis histology and
ultrastructure also induces a reduction in sperm motility
and density. Other authors have also described a reduc-
tion in epididymal sperm counts and sperm motility in
rats treated with other chromium compounds, namely
CrO3 [20]. Here, the reduction of acrosome sperm integ-
rity in mice exposed to Cr(V) is a sign of sperm lost of fer-
tilizing potential, reflecting its inability to penetrate the
zona pellucida [29]. Our previous studies have shown
that Cr(V) affected the functional properties of Sertoli
cells [24]. These results show evidence that other compo-
nents of testis are important toxicological targets of Cr(V)
compounds.
Keeping in mind that the mammalian testis and epidi-
dymis provide a suitable and necessary environment for
spermatogenesis, maturation, and storage of spermato-
zoa, the damaged induced by [CrV-BT]2-  compound
appears of great importance in the understanding of the
biological effects of chromium in regard to male repro-
ductive function.
Further studies are now underway in our laboratories con-
cerning other organs and other type of experiments,
which combine different factors such as several doses,
time intervals, and different chromium compounds. The
aim is to obtain dose-response data and eventually to
identify toxicity limits of toxicology for these types of
compounds and finally to clarify the mechanisms of chro-
mium induced toxicity.
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